Full Press Release Details
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Cytopoint Plus is the first and only USDA-licensed next-generation mAb that provides 75 days of allergic itch relief in a single injection.
ZTS Positive Sentiment
Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis
Key Takeaway: Zoetis received USDA licensing for Cytopoint Plus, a next-generation monoclonal antibody. The treatment provides 75 days of allergic itch relief in dogs with allergic dermatitis via a single injection. This marks the first long-acting option of its kind approved by the agency.
Market Sentiment Analysis
POSITIVE FACTORS
- Cytopoint Plus offers 75 days of relief.
- It's the first USDA-licensed long-acting mAb.
- Provides a solution for dogs with allergic dermatitis.
Frequently Asked Questions
What is Cytopoint Plus?
Cytopoint Plus is a monoclonal antibody for allergic itch relief in dogs.
How long does Cytopoint Plus provide relief?
It provides 75 days of allergic itch relief with a single injection.
Who licensed Cytopoint Plus?
Cytopoint Plus is licensed by the USDA.
What condition does Cytopoint Plus treat?
It treats allergic dermatitis in dogs.